Answers are grounded in this paper and cite their sources.
Background: Hypoxic-Ischemic Encephalopathy (HIE) is a leading cause of neonatal mortality and morbidity, commonly managed with therapeutic hypothermia (TH), supportive care, and outpatient therapies. Despite TH, nearly half of affected neonates experience mortality or major neurodevelopmental disability, prompting investigation of adjunct therapies. This narrative review examined the potential role of osteopathic manipulative treatment and therapy (OMT/OMTh) in improving outcomes for neonates with HIE.Objective: Review and synthesize existing studies on the effect of OMT/OMTh on motor and neurodevelopmental outcomes in neonates and infants with HIE, neonatal encephalopathy (NE), or perinatal hypoxic-ischemic central nervous system injury.Methods: A literature search was conducted in the Cochrane Library, PubMed/MEDLINE, Scopus, and EMBASE databases without language or date restrictions. Studies were included if they evaluated OMT/OMTh as an intervention in neonates with HIE or neonatal encephalopathy. Data from four studies—one U.S. study and three Russian studies—were analyzed.Results: Preliminary findings from the included studies suggested possible benefits in motor development, movement disorders (notably dystonia), and resolution of reported somatic dysfunctions. NICU length of stay (LOS) was reduced in one U.S. pilot study before sensitivity analysis, while the adjusted comparison was not statistically significant. Three Russian controlled studies reported improvements in selected neurodevelopmental or motor outcomes, but randomization methods, allocation concealment, assessor blinding, outcome-tool validation, and adverse-event monitoring were incompletely reported. One study reported no adverse events; three studies did not specifically report adverse-event outcomes. These limitations preclude definitive conclusions regarding efficacy or HIE-specific safety.Conclusions: OMT/OMTh may be a feasible adjunctive therapy for selected neonates and infants recovering from HIE, NE, or perinatal hypoxic-ischemic injury, with preliminary evidence suggesting possible benefit in motor and neurodevelopmental domains. However, the current evidence is low quality and limited by small sample sizes, heterogeneous terminology, variable treatment protocols, incomplete reporting of study methods, and insufficient safety reporting. Rigorous prospective trials integrated with current HIE standard-of-care protocols are required before efficacy or safety can be established.
No takes yet. Share an insight, caveat, or question.
Gianneschi et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: